Contract awarded for products that bring improvement to healthcare industry New York (March 2, 2026)– Cresilon announced its revolutionary hemostatic gel TRAUMAGEL® has received an Innovative Technology contract from Vizient® the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on review of TRAUMAGEL from hospital experts who serve on one of […] The post Cresilon Receives Innovative Technology Contract from Vizient for TRAUMAGEL appeared first on Cresilon .